FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125346945> ?p ?o ?g. }

• W2125346945 endingPage "854" @default.
• W2125346945 startingPage "844" @default.
• W2125346945 abstract "The study measured the effects of atypical antipsychotics on psychiatric and behavioral symptoms in patients with Alzheimer's disease and psychosis or agitated behavior.The Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer's Disease (CATIE-AD) Alzheimer's disease effectiveness study included 421 outpatients with Alzheimer's disease and psychosis or agitated/aggressive behavior. Patients were assigned randomly to masked, flexible-dose treatment with olanzapine, quetiapine, risperidone, or placebo for up to 36 weeks. Patients could be randomly reassigned to a different medication at the clinician's discretion, which ended phase 1. Psychiatric and behavioral symptoms, functioning, cognition, care needs, and quality of life were measured at regular intervals.In relation to placebo, the last observation in phase 1 showed greater improvement with olanzapine or risperidone on the Neuropsychiatric Inventory total score, risperidone on the Clinical Global Impression of Changes, olanzapine and risperidone on the Brief Psychiatric Rating Scale (BPRS) hostile suspiciousness factor, and risperidone on the BPRS psychosis factor. There was worsening with olanzapine on the BPRS withdrawn depression factor. Among patients continuing phase 1 treatment at 12 weeks, there were no significant differences between antipsychotics and placebo on cognition, functioning, care needs, or quality of life, except for worsened functioning with olanzapine compared to placebo.In this descriptive analysis of outpatients with Alzheimer's disease in usual care settings, some clinical symptoms improved with atypical antipsychotics. Antipsychotics may be more effective for particular symptoms, such as anger, aggression, and paranoid ideas. They do not appear to improve functioning, care needs, or quality of life." @default.
• W2125346945 created "2016-06-24" @default.
• W2125346945 creator A5002451678 @default.
• W2125346945 creator A5018782725 @default.
• W2125346945 creator A5024200262 @default.
• W2125346945 creator A5027752754 @default.
• W2125346945 creator A5036507830 @default.
• W2125346945 creator A5036718203 @default.
• W2125346945 creator A5041019143 @default.
• W2125346945 creator A5053223016 @default.
• W2125346945 creator A5059020389 @default.
• W2125346945 creator A5075093461 @default.
• W2125346945 date "2008-07-01" @default.
• W2125346945 modified "2023-10-14" @default.
• W2125346945 title "Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial" @default.
• W2125346945 cites W1164896577 @default.
• W2125346945 cites W1847168837 @default.
• W2125346945 cites W1953027527 @default.
• W2125346945 cites W1972294144 @default.
• W2125346945 cites W1977405703 @default.
• W2125346945 cites W1985048555 @default.
• W2125346945 cites W1991517279 @default.
• W2125346945 cites W1996567609 @default.
• W2125346945 cites W1996776294 @default.
• W2125346945 cites W2010094552 @default.
• W2125346945 cites W2013177991 @default.
• W2125346945 cites W2023068500 @default.
• W2125346945 cites W2034934007 @default.
• W2125346945 cites W2044196067 @default.
• W2125346945 cites W2060295545 @default.
• W2125346945 cites W2097992844 @default.
• W2125346945 cites W2098379886 @default.
• W2125346945 cites W2108851081 @default.
• W2125346945 cites W2110850052 @default.
• W2125346945 cites W2111963393 @default.
• W2125346945 cites W2115012618 @default.
• W2125346945 cites W2122813545 @default.
• W2125346945 cites W2123633329 @default.
• W2125346945 cites W2130670546 @default.
• W2125346945 cites W2132592055 @default.
• W2125346945 cites W2132871355 @default.
• W2125346945 cites W2136332296 @default.
• W2125346945 cites W2139785703 @default.
• W2125346945 cites W2150798548 @default.
• W2125346945 cites W2156220037 @default.
• W2125346945 cites W2159155203 @default.
• W2125346945 cites W2162993517 @default.
• W2125346945 cites W2163602955 @default.
• W2125346945 cites W2169849640 @default.
• W2125346945 cites W2193764494 @default.
• W2125346945 cites W2222602361 @default.
• W2125346945 cites W2593356281 @default.
• W2125346945 cites W2978911719 @default.
• W2125346945 cites W94895759 @default.
• W2125346945 doi "https://doi.org/10.1176/appi.ajp.2008.07111779" @default.
• W2125346945 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2714365" @default.
• W2125346945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18519523" @default.
• W2125346945 hasPublicationYear "2008" @default.
• W2125346945 type Work @default.
• W2125346945 sameAs 2125346945 @default.
• W2125346945 citedByCount "261" @default.
• W2125346945 countsByYear W21253469452012 @default.
• W2125346945 countsByYear W21253469452013 @default.
• W2125346945 countsByYear W21253469452014 @default.
• W2125346945 countsByYear W21253469452015 @default.
• W2125346945 countsByYear W21253469452016 @default.
• W2125346945 countsByYear W21253469452017 @default.
• W2125346945 countsByYear W21253469452018 @default.
• W2125346945 countsByYear W21253469452019 @default.
• W2125346945 countsByYear W21253469452020 @default.
• W2125346945 countsByYear W21253469452021 @default.
• W2125346945 countsByYear W21253469452022 @default.
• W2125346945 countsByYear W21253469452023 @default.
• W2125346945 crossrefType "journal-article" @default.
• W2125346945 hasAuthorship W2125346945A5002451678 @default.
• W2125346945 hasAuthorship W2125346945A5018782725 @default.
• W2125346945 hasAuthorship W2125346945A5024200262 @default.
• W2125346945 hasAuthorship W2125346945A5027752754 @default.
• W2125346945 hasAuthorship W2125346945A5036507830 @default.
• W2125346945 hasAuthorship W2125346945A5036718203 @default.
• W2125346945 hasAuthorship W2125346945A5041019143 @default.
• W2125346945 hasAuthorship W2125346945A5053223016 @default.
• W2125346945 hasAuthorship W2125346945A5059020389 @default.
• W2125346945 hasAuthorship W2125346945A5075093461 @default.
• W2125346945 hasBestOaLocation W21253469452 @default.
• W2125346945 hasConcept C118552586 @default.
• W2125346945 hasConcept C142724271 @default.
• W2125346945 hasConcept C15744967 @default.
• W2125346945 hasConcept C204787440 @default.
• W2125346945 hasConcept C27081682 @default.
• W2125346945 hasConcept C2776153860 @default.
• W2125346945 hasConcept C2776412080 @default.
• W2125346945 hasConcept C2776619155 @default.
• W2125346945 hasConcept C2776921671 @default.
• W2125346945 hasConcept C2778528637 @default.
• W2125346945 hasConcept C2779437044 @default.
• W2125346945 hasConcept C2779727114 @default.
• W2125346945 hasConcept C2780057945 @default.

• next